HCV coinfection of the HIV-infected patients with discordant CD4(+) T-cell response to antiretroviral therapy leads to intense systemic inflammation

HIV感染者若同时感染HCV,且对抗逆转录病毒疗法的CD4(+) T细胞反应不一致,则会导致严重的全身性炎症反应。

阅读:1

Abstract

The level of proinflammatory markers was assessed in HIV-infected patients that were coinfected with hepatitis C virus (HCV) and had failed to restore the CD4(+) T cell counts (immunological nonresponders, INR) during the antiretroviral therapy (ART). Among four patient groups (HIV(+)HCV(-) and HIV(+)HCV(+) subjects with the concordant response to ART; HIV(+)HCV(-) and HIV(+)HCV(+) subjects that were INR), the greatest systemic inflammation was in the latter group. The maximum difference was between the subjects HIV(+)HCV(-)INR and HIV(+)HCV(+) INR: the blood of coinfected patients contained significantly higher concentrations of the IP-10, sCD163, sTNF-RI, and sTNF-RII and of bacterial lipopolysaccharide. Systemic inflammation in HIV/HCV coinfected patients with the discordant response to ART is probably caused by a breach of hepatic barrier for the intestine products.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。